amantadine has been researched along with homovanillic acid in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (61.90) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gray, MW; Herzberg, L; Lerman, JA; Turnbull, MJ; Victoratos, G | 1 |
| Fleming, AM; Lenman, JA; Reid, A; Turnbull, MJ | 1 |
| Bariletto, S; Dollar, E; Leitz, F | 1 |
| Cox, B | 1 |
| Altagracia, M; Kravsov, J; Rios, C; Rojas, P | 1 |
| Chan, WW; Rausch, WD; Riederer, P; Schallauer, E; Weiser, M | 1 |
| Botez, MI; Botez, T; Pedraza, OL; Young, SN | 1 |
| Toide, K | 1 |
| Dunn, JP; Gianutsos, G; Henkel, JG | 1 |
| Lahti, RA; McAllister, B; Wozniak, J | 1 |
| Ahtee, L; Kääriäinen, I; Paasonen, MK | 1 |
| Jones, DG; Lenman, JA; Robertson, MA; Turnbull, MJ | 1 |
| Cox, B; Danta, G; Schnieden, H; Yuill, GM | 1 |
| Fodor, A; Molnár, G | 1 |
| Chase, TN; Glaubiger, GA; Woods, AC | 1 |
| Colucci d'Amato, C; Cristillo, A; Puccini, A; Vizioli, R | 1 |
| Fuller, RW; Perry, KW; Snoddy, HD | 1 |
| Altagracia, M; Kravzov, J; Rios, C; Rojas, P | 1 |
| Kawai, H; Mitsui, T; Miyata, M; Saito, S; Sakoda, S | 1 |
| Danysz, W; Hesselink, M; Quack, G; Spanagel, R | 1 |
| Asai, M; Ashikari, I; Kanba, S; Ohnishi, K; Yagi, G; Yamada, K | 1 |
1 review(s) available for amantadine and homovanillic acid
| Article | Year |
|---|---|
[Biochemical bases of Parkinson disease].
Topics: Acetylcholine; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Dopa Decarboxylase; Dopamine; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Receptors, Dopamine; Selegiline; Serotonin; Substantia Nigra; Tyrosine 3-Monooxygenase | 1984 |
2 trial(s) available for amantadine and homovanillic acid
| Article | Year |
|---|---|
Treatment of heredo-degenerative ataxias with amantadine hydrochloride.
Topics: Adult; Amantadine; Female; Friedreich Ataxia; Homovanillic Acid; Humans; Male; Middle Aged; Muscles; Olivopontocerebellar Atrophies; Reaction Time | 1991 |
Parkinson disease treated with a suspected dopamine receptor agonist.
Topics: Adult; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Dihydroxyphenylalanine; Dopamine; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Piperazines; Placebos; Probenecid; Pyrimidines; Receptors, Cholinergic; Tremor; Trihexyphenidyl | 1974 |
18 other study(ies) available for amantadine and homovanillic acid
| Article | Year |
|---|---|
Letter: Amantadine in chorea.
Topics: Aged; Amantadine; Chorea; Drug Evaluation; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid | 1975 |
Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
Topics: Amantadine; Chorea; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methylhistamines; Middle Aged; Movement Disorders; Parkinson Disease; Phenylacetates; Tremor | 1977 |
Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Catechols; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Methyltyrosines; Rats; Tritium; Tyrosine | 1975 |
Amantadine and apomorphine: interactions on striatal dopamine receptors.
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Interactions; Homovanillic Acid; Humans; Monoamine Oxidase Inhibitors; Rats; Receptors, Drug; Stereotyped Behavior; Time Factors | 1975 |
Partially protective effect of amantadine in the MPTP model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Parkinson Disease, Secondary | 1992 |
Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Caudate Nucleus; Corpus Striatum; Dopamine; Drug Interactions; Female; Gerbillinae; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Parkinson Disease, Secondary; Selegiline; Serotonin | 1990 |
Effects of amantadine on dopaminergic neurons in discrete regions of the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Brain; Cerebral Cortex; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Neurons; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Tyrosine 3-Monooxygenase | 1990 |
Pharmacological activity of amantadine: effect of N-alkyl substitution.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alkylation; Amantadine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Homovanillic Acid; In Vitro Techniques; Male; Mice; Motor Activity; Rats; Receptors, Dopamine; Structure-Activity Relationship; Synaptosomes | 1986 |
Apomorphine antagonism of the elevation of homovanillic acid induced by antipsychotic drugs.
Topics: Amantadine; Animals; Apomorphine; Brain; Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; Haloperidol; Homovanillic Acid; Mice; Morphine; Phenylacetates; Receptors, Adrenergic; Structure-Activity Relationship; Synaptic Transmission; Thiothixene; Tranquilizing Agents; Trifluoperazine | 1972 |
Effect of nalorphine and antiparkinsonian drugs on methadone-induced rigidity; relation to homovanillic acid content of nucleus caudatus.
Topics: Amantadine; Animals; Atropine; Body Temperature; Brain; Caudate Nucleus; Depression, Chemical; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Methadone; Muscle Rigidity; Muscle Tonus; Nalorphine; Parasympatholytics; Phenylacetates; Rats; Serotonin; Spectrometry, Fluorescence; Trihexyphenidyl | 1972 |
Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.
Topics: Amantadine; Amines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Histamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Norepinephrine; Parkinson Disease; Phenylacetates | 1972 |
Interactions of L-dopa and amantadine in patients with Parkinsonism.
Topics: Amantadine; Dihydroxyphenylalanine; Drug Interactions; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Male; Middle Aged; Muscle Rigidity; Muscles; Parkinson Disease; Tremor | 1973 |
Responses of the urinary excretion of homovanillic acid and of 5-hydroxy-indol-acetic acid to treatment with L-dopa and amantadine.
Topics: Amantadine; Dihydroxyphenylalanine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Parkinson Disease; Phenylacetates | 1973 |
Comparative effects of amantadine and amfonelic acid on dopamine metabolism in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Brain; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Male; Nalidixic Acid; Naphthyridines; Rats; Receptors, Dopamine | 1981 |
Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Parkinson Disease, Secondary; Probenecid; Serotonin | 1993 |
Hereditary parkinsonism with multiple system degeneration: beneficial effect of anticholinergics, but not of levodopa.
Topics: Adult; Amantadine; Basal Ganglia; Carbidopa; Cerebellar Ataxia; Cholinergic Antagonists; Consanguinity; Drug Resistance; Female; Genes, Recessive; Globus Pallidus; Homovanillic Acid; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease; Pedigree; Trihexyphenidyl | 1994 |
Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Antiparkinson Agents; Brain; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Homovanillic Acid; Male; Memantine; Microdialysis; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1995 |
Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
Topics: Adult; Aged; Amantadine; Chronic Disease; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1997 |